| Lakeview Center Inc | |
|
1221 W Lakeview Ave Pensacola FL 32501-1857 | |
| (850) 469-3500 | |
| (850) 469-3424 |
| Full Name | Lakeview Center Inc |
|---|---|
| Speciality | Clinic/Center |
| Location | 1221 W Lakeview Ave, Pensacola, Florida |
| Authorized Official Name and Position | Eric Barley (CFO) |
| Authorized Official Contact | 8504321222 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Lakeview Center Inc 1221 W Lakeview Ave Pensacola FL 32501-1857 Ph: (850) 469-3500 | Lakeview Center Inc 1221 W Lakeview Ave Pensacola FL 32501-1857 Ph: (850) 469-3500 |
| NPI Number | 1316943772 |
|---|---|
| Provider Enumeration Date | 06/21/2005 |
| Last Update Date | 02/08/2024 |
| Certification Date | 02/08/2024 |
| Medicare PECOS PAC ID | 3375439904 |
|---|---|
| Medicare Enrollment ID | O20040223000324 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316943772 | NPI | - | NPPES |
| 060271004 | Medicaid | FL | |
| 141282500 | Medicaid | FL | |
| 141280900 | Medicaid | FL | |
| 060271000 | Medicaid | FL | |
| 060271002 | Medicaid | FL | |
| 141281700 | Medicaid | FL | |
| 141283300 | Medicaid | FL | |
| 024488196 | Medicaid | FL | |
| 060271019 | Medicaid | FL |
| Provider Name | Robert A Althar |
|---|---|
| Provider Type | Practitioner - Addiction Medicine |
| Provider Identifiers | NPI Number: 1487655155 PECOS PAC ID: 7719941822 Enrollment ID: I20041118000324 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Myron D Almond |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1699760405 PECOS PAC ID: 0042277659 Enrollment ID: I20041215000677 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Fadel A Salib |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1295719961 PECOS PAC ID: 4486688066 Enrollment ID: I20050923000199 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Douglas H Fraser |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1821188038 PECOS PAC ID: 2769587757 Enrollment ID: I20070419000582 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Stephen J Chesser |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1578696977 PECOS PAC ID: 9234201112 Enrollment ID: I20080709000660 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Catharine D Johnson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1518987460 PECOS PAC ID: 7911065263 Enrollment ID: I20081015000495 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Guido Ludergnani |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1407990856 PECOS PAC ID: 4486635398 Enrollment ID: I20090310000087 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Luis C Lemus |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1467447342 PECOS PAC ID: 4183750029 Enrollment ID: I20100330000580 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Mary-jane Valbracht |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1699874545 PECOS PAC ID: 1254523574 Enrollment ID: I20101005001000 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Terry E Ptacek |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1437121175 PECOS PAC ID: 7517159643 Enrollment ID: I20101007001150 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Annie Cherian |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1578547246 PECOS PAC ID: 3870787013 Enrollment ID: I20101101001130 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Venkata Sompalli |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1104800879 PECOS PAC ID: 1456546498 Enrollment ID: I20101116000475 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Nancy D Hart |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1073536603 PECOS PAC ID: 1254520380 Enrollment ID: I20110105000750 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Lourdes Ferrer Quiray |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1851385959 PECOS PAC ID: 4880873579 Enrollment ID: I20110127000267 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Kaberi Samanta |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1093700973 PECOS PAC ID: 0244415511 Enrollment ID: I20110502000212 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Cynthia Javellana |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1306821640 PECOS PAC ID: 1557547080 Enrollment ID: I20110518000678 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Tanya Y Theriault |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1093919284 PECOS PAC ID: 8527236736 Enrollment ID: I20110713000851 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Kay L Norris |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1144534041 PECOS PAC ID: 7618165150 Enrollment ID: I20130306000599 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Scott A. Mcintosh |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1437388659 PECOS PAC ID: 2860623097 Enrollment ID: I20140821001791 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Timothy C Rowell |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1023393899 PECOS PAC ID: 6002037819 Enrollment ID: I20141021000046 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Jennifer Upcraft |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1629499504 PECOS PAC ID: 4981920329 Enrollment ID: I20150303001109 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Katrina Crane |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1790177608 PECOS PAC ID: 1951629385 Enrollment ID: I20150415002431 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Praveen Narahari |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1053549832 PECOS PAC ID: 6002060498 Enrollment ID: I20150505002655 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Erin S Vaughn |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1417346362 PECOS PAC ID: 7517287584 Enrollment ID: I20150515000410 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Shelby L Amaral |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1609246412 PECOS PAC ID: 2860770302 Enrollment ID: I20161103000936 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Kimberly Ret |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1871030841 PECOS PAC ID: 4284911264 Enrollment ID: I20170428001301 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | John David R Sheffield |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1194199976 PECOS PAC ID: 0941509830 Enrollment ID: I20170612000291 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Susan K Michaels |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1801280458 PECOS PAC ID: 8628347705 Enrollment ID: I20170705001778 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Brandie L Crawford |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1194244558 PECOS PAC ID: 5597024760 Enrollment ID: I20180116000326 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Sarah Skinner |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1942511605 PECOS PAC ID: 1456492081 Enrollment ID: I20180223000258 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Richard B Lowery |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1841688918 PECOS PAC ID: 3577875574 Enrollment ID: I20180305000583 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Francheska N Barrett |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1497255707 PECOS PAC ID: 0547524175 Enrollment ID: I20180508001796 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Igor Bogunovic |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1407375694 PECOS PAC ID: 7214292358 Enrollment ID: I20180521001250 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Marcia M Binion |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1477056943 PECOS PAC ID: 4284999848 Enrollment ID: I20180531001655 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Warren H Scott |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1023073350 PECOS PAC ID: 9931120557 Enrollment ID: I20180705000630 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Renee Santonia Mccorcle |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1851769715 PECOS PAC ID: 8729397658 Enrollment ID: I20190227001340 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Paul Anthony Alvarado |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1013487370 PECOS PAC ID: 8022344118 Enrollment ID: I20190726002101 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | William Imbrie Packard |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1730293796 PECOS PAC ID: 9436258183 Enrollment ID: I20190729002050 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Brandy Michelle Mihaly |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1669939724 PECOS PAC ID: 4880923168 Enrollment ID: I20190911003359 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Crystal Nichole Jones-lindsey |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1285198598 PECOS PAC ID: 4183955081 Enrollment ID: I20191008000082 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Joshua Waddell |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1053862862 PECOS PAC ID: 1254764046 Enrollment ID: I20191210000191 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Afua Ntiwa |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1447713581 PECOS PAC ID: 9739512229 Enrollment ID: I20191216000746 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Ashley Nicole Wei |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1457992968 PECOS PAC ID: 2860826146 Enrollment ID: I20191219000034 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Aaron Oree Godwin |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1013194703 PECOS PAC ID: 3971665092 Enrollment ID: I20200225002358 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Danielle Pugh |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1639718455 PECOS PAC ID: 4082044136 Enrollment ID: I20200414001150 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Clare Sophia Walter |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1235522897 PECOS PAC ID: 5092137356 Enrollment ID: I20200616000804 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Callie Callaway |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1073973749 PECOS PAC ID: 5597049957 Enrollment ID: I20200619001275 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Jennifer D Grady |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1548889215 PECOS PAC ID: 0840613915 Enrollment ID: I20200708000652 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Rhonda R Mcpherson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1194263715 PECOS PAC ID: 5597183087 Enrollment ID: I20200915003340 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Jonathan Hoffman |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1770182875 PECOS PAC ID: 3476963331 Enrollment ID: I20201104000286 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Stephen Clark Richardson |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1639523400 PECOS PAC ID: 1153617782 Enrollment ID: I20201104001645 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Jeaninne Atherton |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1922566546 PECOS PAC ID: 8729498654 Enrollment ID: I20201105000063 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Sandra Kay Crawford |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1033527585 PECOS PAC ID: 3476963240 Enrollment ID: I20201105001814 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Amanda Helm |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1366911877 PECOS PAC ID: 2264842038 Enrollment ID: I20201105001960 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Dustin Perry |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1790220440 PECOS PAC ID: 0648680389 Enrollment ID: I20201109000099 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Ann Lewis |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1558357194 PECOS PAC ID: 8527478965 Enrollment ID: I20201113000862 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Delivian Yvonne Davis |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1255869111 PECOS PAC ID: 9830500149 Enrollment ID: I20201117002466 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Patti Hyde |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1164847588 PECOS PAC ID: 6507278025 Enrollment ID: I20201207002042 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | John Cheatwood |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1669984845 PECOS PAC ID: 6709132210 Enrollment ID: I20201210000926 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Tamara Ramos |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1316489230 PECOS PAC ID: 4082027032 Enrollment ID: I20210112000362 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Katie Lloyd |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1780187682 PECOS PAC ID: 7911307392 Enrollment ID: I20210608000702 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Amanda Liles |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1679144877 PECOS PAC ID: 3577957398 Enrollment ID: I20220221002108 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Jamie Karrh |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1992455661 PECOS PAC ID: 9931596400 Enrollment ID: I20220502001148 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Maria Rowan |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1700519360 PECOS PAC ID: 4981080850 Enrollment ID: I20220929001498 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Jacqueline Coleman |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1396466132 PECOS PAC ID: 2163899733 Enrollment ID: I20221110002782 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Michael C Tavares |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1558089276 PECOS PAC ID: 6103296520 Enrollment ID: I20221229002154 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Courtney Brue |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1568006534 PECOS PAC ID: 0345612370 Enrollment ID: I20230220002786 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Eric Wilkinson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1396442232 PECOS PAC ID: 8527431576 Enrollment ID: I20230222002512 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Candis D'anne Calvert |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1376260596 PECOS PAC ID: 3870966757 Enrollment ID: I20230223000541 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Kylee J Dalton |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1568170116 PECOS PAC ID: 7618340324 Enrollment ID: I20230228001881 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Talisman Lundy-lleshi |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1548561160 PECOS PAC ID: 2567835002 Enrollment ID: I20230302001766 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Robert Shawn Majors |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1033844873 PECOS PAC ID: 9032582549 Enrollment ID: I20230303001278 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Stephanie A Ellerbe |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1962834499 PECOS PAC ID: 3971739269 Enrollment ID: I20230316001780 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Kathleen Delancey |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1376133520 PECOS PAC ID: 7113315029 Enrollment ID: I20230403000152 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Jessica Leigh Swanson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1467144741 PECOS PAC ID: 9638536667 Enrollment ID: I20230607001884 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Ryan Ardoin |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1770295743 PECOS PAC ID: 2961860085 Enrollment ID: I20230622001225 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Heather Danielle Morris |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1467143891 PECOS PAC ID: 1658739685 Enrollment ID: I20230622002383 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Randolph Nace |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1831873173 PECOS PAC ID: 5799143756 Enrollment ID: I20230622003629 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Stanislav Kruglikov |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1316048986 PECOS PAC ID: 2860414281 Enrollment ID: I20230921000923 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Angela Rowand Mills |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1508642885 PECOS PAC ID: 1456705680 Enrollment ID: I20230921003272 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Victoria Bailey Gunter |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1215711452 PECOS PAC ID: 9638523657 Enrollment ID: I20230925003900 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Hailey Celeste Vascik |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1144008350 PECOS PAC ID: 2365898756 Enrollment ID: I20231020001177 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Victoria Lynnette Wallace |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1942931340 PECOS PAC ID: 2961850680 Enrollment ID: I20231118000258 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Rachel Battiste-janssen |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1528581634 PECOS PAC ID: 8325496383 Enrollment ID: I20231130003919 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Franklin Kent Beall |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1033762273 PECOS PAC ID: 5496103400 Enrollment ID: I20231201001729 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Suzanne Cecelia Cobbs |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1932261112 PECOS PAC ID: 5294183141 Enrollment ID: I20231202000646 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Stephen Pope Mccrary |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1457501272 PECOS PAC ID: 0941658835 Enrollment ID: I20231204001245 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Laura Carroll |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1699808667 PECOS PAC ID: 5991153736 Enrollment ID: I20231204003718 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Marchella Shawntell Carter |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1841841293 PECOS PAC ID: 7911355763 Enrollment ID: I20231205000235 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Ryan Christopher Campbell |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1356818991 PECOS PAC ID: 5092164897 Enrollment ID: I20231205002408 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Kristopher Fross |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1619517984 PECOS PAC ID: 9234588047 Enrollment ID: I20231205002972 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Vanessa Ann Byerly |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1568245694 PECOS PAC ID: 8527417344 Enrollment ID: I20231205003294 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Bonnie Lee Cox |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1891763322 PECOS PAC ID: 4385093111 Enrollment ID: I20231205003539 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Lynne Johnson |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1174645758 PECOS PAC ID: 7810346699 Enrollment ID: I20231206001824 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Stephanie Woodham Guidry |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1295901106 PECOS PAC ID: 6305295080 Enrollment ID: I20231206002121 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Nealofier M Lewis-rhodes |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1831849603 PECOS PAC ID: 5890144596 Enrollment ID: I20231206002762 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Tonya Kerchoff |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1164456174 PECOS PAC ID: 6305295049 Enrollment ID: I20231207000199 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Ashtin Nicole Lafountain |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1407386402 PECOS PAC ID: 3870942527 Enrollment ID: I20231207000571 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Margaret E Lamotte |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1376192534 PECOS PAC ID: 7315396066 Enrollment ID: I20231207000587 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Lena T. Longmire-lyons |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1922737410 PECOS PAC ID: 6901255678 Enrollment ID: I20231207001635 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Debra Denise Braswell |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1124769682 PECOS PAC ID: 0547619124 Enrollment ID: I20231207002036 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Julia Hoeschler |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1811771256 PECOS PAC ID: 0941659577 Enrollment ID: I20231207004047 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Vonetta Richette O'garro |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1063917755 PECOS PAC ID: 6305295932 Enrollment ID: I20231207004076 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Elizabeth Eugenia Kitchens |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1710905922 PECOS PAC ID: 3274982806 Enrollment ID: I20231208000037 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Jason Carroll |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1770845588 PECOS PAC ID: 6204285851 Enrollment ID: I20231208000639 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Laura Michelle Bearden |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1396209490 PECOS PAC ID: 2163871625 Enrollment ID: I20231208001160 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Cynthia J Lundquist |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1437401239 PECOS PAC ID: 2567811029 Enrollment ID: I20231208001417 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Tammy Moore |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1982690400 PECOS PAC ID: 8022467596 Enrollment ID: I20231208001783 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Deidre Maria Christina George-mullins |
|---|---|
| Provider Type | Practitioner - Marriage And Family Therapist |
| Provider Identifiers | NPI Number: 1225157381 PECOS PAC ID: 7810346392 Enrollment ID: I20231208001944 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Dana Marie Edwards |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1053192989 PECOS PAC ID: 0345699823 Enrollment ID: I20231208002029 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | James Rhodes |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1639193634 PECOS PAC ID: 0840649372 Enrollment ID: I20231209000585 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Claire Griffin Evans |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1619586674 PECOS PAC ID: 7517316052 Enrollment ID: I20231210000059 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Sweneda Danielle Mcdonald |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1871017590 PECOS PAC ID: 6709235153 Enrollment ID: I20231211000562 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Meredith Olsen |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1972188993 PECOS PAC ID: 8921457375 Enrollment ID: I20231211000678 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Brittany Anne Williams |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1518389865 PECOS PAC ID: 0042669426 Enrollment ID: I20231211001758 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Mary Elizabeth Popovich |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1760471767 PECOS PAC ID: 7113376500 Enrollment ID: I20231211001814 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Charetta Roberts |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1366834582 PECOS PAC ID: 8628427036 Enrollment ID: I20231211002946 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Keith Tucker |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1053307579 PECOS PAC ID: 2668821083 Enrollment ID: I20231211003220 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Linda Michelle Wiesand |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1174740286 PECOS PAC ID: 6800245226 Enrollment ID: I20231211003382 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Nathalie Elizabeth Williams |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1942631544 PECOS PAC ID: 2365891793 Enrollment ID: I20231212000059 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Larry Raymond Pierson |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1528679818 PECOS PAC ID: 0648629972 Enrollment ID: I20231212004094 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Thomasyne Luan Yardley |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1861451932 PECOS PAC ID: 9931558053 Enrollment ID: I20231213004118 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Stephen Michael Soderlind |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1356441083 PECOS PAC ID: 5698124600 Enrollment ID: I20231214003643 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Brooke Elizabeth Schang |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1730803578 PECOS PAC ID: 7416307301 Enrollment ID: I20231218004028 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Amy Gokey |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1083042832 PECOS PAC ID: 8820448632 Enrollment ID: I20231220000392 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Autumn Elizabeth Mcallister |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1134511983 PECOS PAC ID: 0648620310 Enrollment ID: I20231220003351 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Kelli Reed |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1144573668 PECOS PAC ID: 4789917071 Enrollment ID: I20240117002268 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
| Provider Name | Anthony Morris |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1144744335 PECOS PAC ID: 3476996414 Enrollment ID: I20240207001454 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.
Political Pro talks to researchers who helped develop the IOM recommendations for the federal government on what should be offered in health plans. At the same time, a number of media outlets look at news about the implementation of the 2010 health care law.
A new statistical technique offers a better way to gauge the effectiveness of complex healthcare interventions.
› Verified 2 days ago
Behavioral Assessment And Intervention Solutions Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 124 Redbreast Ln, Pensacola, FL 32503 Phone: 850-426-3999 | |
Pamela Downey Counseling Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 310 E Government St, Pensacola, FL 32502 Phone: 850-529-4595 Fax: 850-361-3382 | |
Antidote Wellness Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 5435 Japonica Ave, Pensacola, FL 32507 Phone: 850-332-3087 | |
A Little Therapy, Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 8511 Myslak Way Unit 2210, Pensacola, FL 32526 Phone: 850-601-1679 | |
Coastline Neuropsychiatric Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 890 S Palafox St Suite 300-l, Pensacola, FL 32502 Phone: 850-341-4896 Fax: 850-433-1996 | |
Meaningful Moments Therapeutic Services, Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 1576 Airport Blvd, Pensacola, FL 32504 Phone: 504-783-8888 | |
Kr Counseling Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 6866 Pine Forest Rd Ste A, Pensacola, FL 32526 Phone: 850-670-2300 |